AOD-9604

peptide · endocrine · musculoskeletal · Subcutaneous

AOD-9604, a peptide. 15-aa C-terminal lipolytic fragment of human GH (residues 177-191) plus an N-terminal tyrosine. Proposed to retain GH's lipolytic / antilipogenic…

15-aa C-terminal lipolytic fragment of human GH (residues 177-191) plus an N-terminal tyrosine. Proposed to retain GH's lipolytic / antilipogenic activity without the diabetogenic full-molecule effects. FDA phase 2 obesity trials failed to show weight loss. Marketing claims far outpace evidence.